Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-25 @ 7:22 PM
Study NCT ID:
NCT03989232
Status:
COMPLETED
Last Update Posted:
2023-02-13
First Post:
2019-06-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-14
First Submit QC Date:
None
Study First Post Date:
2019-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-04
Results First Submit QC Date:
None
Results First Post Date:
2021-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-10
Last Update Post Date:
2023-02-13
Last Update Post Date Type:
ACTUAL